Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease
Clinical trial NCT06623110 · RECRUITING
Trial details
- NCT number
- NCT06623110
- Sponsor
- Glenn J. Hanna
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2027-01-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.